QBie™ Spotlight: Premier Biomedical Inc (OTCQB: BIEI)


QBie™ Spotlight: Premier Biomedical Inc (OTCQB: BIEI)

QBie™ Spotlight joins William A. Hartman, President & CEO, of Premier Biomedical Inc (OTCQB: BIEI), to discuss one of the OTCQB’s newest additions. BIEI joined the OTCQB on July 27, 2018.


What does Premier Biomedical do?

William A. Hartman (President & CEO – OTCQB: BIEI): “We launched the company in 2010 as an R&D company, but relaunched in 2017 also specializing in topical pain relief products featuring CBD hemp oil products. In January, 2017, we had one product, but today, we have eight products with a proprietary blend of ingredients featuring more CBD than competition at lower prices. We specialize in topical pain relief products as an effective alternative to dangerous and addictive opioid pain medications, which are a major causal factor in the 200 drug overdose deaths per day in the United States.”


What is the next big goal BIEI is trying to accomplish/what should we keep an eye out for?

William A. Hartman: “Two major events: 1) We signed an agreement with a group specializing in sales to the military and government, and we eagerly await an anticipated supply agreement; and 2) We are about to sign a joint venture off-shore that will increase our market substantially.”


Why did you join the OTCQB/go public?

William A. Hartman: “Increased confidence of the stockholder base.”


Learn more at www.premierbiomedical.com or email William Hartman at w.hartman@premierbiomedical.com or williamahartman@aol.com


About QBie™ Spotlight:

QBie™ Spotlight is a virtual “welcome interview” for new OTCQB companies. QBie™ Spotlight helps issuers that are new to the OTCQB connect with microcap industry professionals! Learn more about the QBie™ Spotlight HERE.


Disclaimer/Forward Looking Statements:

This Website and its contents are not to be construed, under any circumstances, as an offer to sell or a solicitation to buy or effect transactions in any securities. No investment advice is provided or should be construed to be provided herein. This Website and its owners, employees and affiliates are not, nor do any of them claim to be, registered broker-dealers or registered investment advisors. This Website may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including, but not limited to, any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements concerning proposed new services or developments; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing. Such forward-looking statements of or concerning the companies mentioned herein are subject to numerous uncertainties and risk factors, including uncertainties and risk factors that may not be set forth herein, which could cause actual results to differ materially from those stated herein. Accordingly, user of this Website are cautioned not to place undue reliance on such forward-looking statements. This Website undertakes no obligation to update any forward-looking statements that may be contained herein.


Leave a Reply